Related Experiment Video
Updated: Jul 5, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
The oriGen case and Mexico's regulatory blind spots in genomic biobanking
1RNA Biology and Genome Editing Section, Molecular Pathogenesis Research Laboratory, Hospital Infantil de México Federico Gómez, Dr. Márquez 162, Doctores, Cuauhtémoc, CP 06720, CDMX, Mexico.
Abstract:
The oriGen project represents a pioneering but institutionally anchored response to Mexico's regulatory gap. Yet, viewed through the lens of contemporary scholarship, its model-private university ownership, broad individual consent, and external sequencing partnerships-stands in tension with emerging global norms for equitable, transparent, and democratically governed genomic research.
Related Concept Videos
Genomics
Pharmacogenomics: Identification of New Drug Targets
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Global Regulatory Systems
